Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence

Affiliations

¹ Private Academic Consultant, Bangkok, Thailand.
² Adjunct professor, Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria; Honorary professor, Dr DY Patil University, Pune, India; visiting professor, Hainan Medical University, Haikou, China.

Comment

Rujittika Mungmunpuntipantip et al. Inflamm Bowel Dis. 2023.

. 2023 Mar 1;29(3):e7.

doi: 10.1093/ibd/izac257.

¹ Private Academic Consultant, Bangkok, Thailand.
² Adjunct professor, Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria; Honorary professor, Dr DY Patil University, Pune, India; visiting professor, Hainan Medical University, Haikou, China.

No abstract available

Comment in

Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination".
Phan H, Hayney MS, Caldera F. Phan H, et al. Inflamm Bowel Dis. 2023 Mar 1;29(3):e8-e9. doi: 10.1093/ibd/izad006. Inflamm Bowel Dis. 2023. PMID: 36715158 No abstract available.

Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination.
Caldera F, Farraye FA, Necela BM, Cogen D, Saha S, Wald A, Daoud ND, Chun K, Grimes I, Lutz M, Van Helden SR, Swift MD, Virk A, Bharucha AE, Patel TC, Gores GJ, Chumsri S, Hayney MS, Knutson KL. Caldera F, et al. Inflamm Bowel Dis. 2023 Aug 1;29(8):1202-1209. doi: 10.1093/ibd/izac193. Inflamm Bowel Dis. 2023. PMID: 36103273 Free PMC article.